Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Current Concepts on the Treatment of Intertrochanteric Fractures to Prevent Nonunion

Version 1 : Received: 22 April 2024 / Approved: 22 April 2024 / Online: 23 April 2024 (03:31:02 CEST)

How to cite: Rodriguez-Merchan, E.C.; Delgado-Martinez, A.D. Current Concepts on the Treatment of Intertrochanteric Fractures to Prevent Nonunion. Preprints 2024, 2024041406. https://doi.org/10.20944/preprints202404.1406.v1 Rodriguez-Merchan, E.C.; Delgado-Martinez, A.D. Current Concepts on the Treatment of Intertrochanteric Fractures to Prevent Nonunion. Preprints 2024, 2024041406. https://doi.org/10.20944/preprints202404.1406.v1

Abstract

Hip fractures are the most frequently treated fractures in the world. Of these, intertrochanteric fractures (ITFs) account for almost 50%. After surgical fixation of ITFs, nonunion is rare. Nonunions are commonly produced from mal-reduction (in varus) and/or inadequate stability of the bone-implant construct and/or fatigue failure of the implants. Other causes of nonunion include posteromedial comminution and osteoporosis. The published incidence of ITF nonunion is 1%-2%. Mechanical complications of ITFs include cut-out, excessive shortening of the proximal femur, delayed union, nonunion, early implant fracture, nail toggle and cut through/medial migration. That is why a fundamental goal in the treatment of ITFs is to achieve stable fixation in osteoporotic bone, allowing early weight bearing. Intraoperative determination of fracture stability is essential. The American Academy of Orthopedic Surgeons (AAOS) clinical practice guidelines for the management of intertrochanteric fractures (ITF) in patients older than 55 years are the following: 1) In patients with stable ITF, the use of either a sliding hip screw (SHS) or a cephalomedullary nail (CMN) is advised (strong strength of evidence). 2) In patients with reverse obliquity fractures, a CMN is recommended (strong strength of evidence). 3) Patients with unstable ITF should be treated with a CMN (strong strength of evidence). 4) In patients with ITF, a short or long CMN may be considered (limited strength of evidence).

Keywords

intertrochanteric fracture; treatment; nonunion; current concepts

Subject

Medicine and Pharmacology, Orthopedics and Sports Medicine

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.